Search

everythinglearnresearchcommunity

for

Search:↓

The main cause of excessive hair growth in Turkish women is Polycystic ovary syndrome, but in about one fifth of cases, the reason for high male hormone levels is unknown.

The conclusion is that a thorough approach is needed to diagnose and manage hyperandrogenism in teenage girls, recognizing its major psychological and health effects.

The document says that early treatment of Acne Vulgaris is important to prevent scarring and that adult onset acne is common in women, often due to hormonal imbalances.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

The document concludes that treatments for female hair loss and excessive hair growth are temporary and not well-studied.

The conclusion is that young women with excessive hair growth should be quickly tested for hormonal issues and treated to improve their social well-being.

The document concludes that managing female hyperandrogenism requires a combination of identifying the cause, lifestyle changes, medication, and cosmetic treatments.

The document concludes that treating androgen excess needs patience, managing expectations is important, and many drugs used are not officially approved, suggesting cosmetic options for mild cases.

Androgen conjugates might be better indicators of skin sensitivity to hormones in women with excessive hair growth.

Hormone imbalances can cause specific skin changes, which may help in early detection of endocrine disorders.

Acne and increased body hair in teenage girls are normal but severe cases may need hormone evaluation and treatment can prevent diabetes linked to PCO.

Excessive hair growth in women can be harmless or signal serious health issues, and treatment often includes medication and hair removal, with noticeable results after 3-6 months.

The document concluded that more research is needed to understand how estrogen affects the enzyme involved in hirsutism development.

Different treatments for PCOS focus on the specific symptoms, with weight loss and lifestyle changes being important.

Hormonal therapy is effective for treating acne in adult women, especially with signs of high androgen levels.

The document concludes that early recognition and treatment of PCOS in adolescents is crucial for managing symptoms and long-term health risks.

Low-dose finasteride reduces excessive hair growth in teenage girls safely and affordably.

Most patients improved with oral contraceptives, but some needed additional treatment.

Effective hirsutism management requires identifying the cause, combining new and traditional treatments, and setting realistic expectations for patients.

Women with nonclassic 21-hydroxylase deficiency can have successful pregnancies through IVF, with certain factors affecting their chances.

The main causes of hirsutism in Jordanian women are PCOS and idiopathic hirsutism.

Antiandrogen treatments combined with oral contraceptives can help manage hair growth and hair loss in women with PCOS.

Antiandrogens can help treat skin conditions like acne and excessive hair in women when used carefully.

People who carry the 21-Hydroxylase Deficiency gene are not more likely to have excessive male hormone levels.

Hirsute women have lower type 2 17β-HSD enzyme levels, which improve with treatment.

Finasteride significantly reduces hair growth in women with idiopathic hirsutism.

The gene SDR5A1 is found in scalp hair of both hirsute and normal individuals, but it does not explain differences in hair growth.

The document concludes that proper diagnosis and tailored long-term treatment can effectively manage androgenic disorders in women, improving patient care outcomes.

The review suggests a comprehensive approach to treat hirsutism, focusing on hair removal, medication, and managing emotional effects.

Women with excessive hair growth or polycystic ovary disease may more often carry a gene variant for 21 hydroxylase deficiency.